Vimarsana
Biggest News Aggregation in the World

Page 16 - Peter Denardo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Denardo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Denardo Today - Breaking & Trending Today

Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth - Vimarsana News

Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth

Published: December 2, 2021

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldPeter DenardoErich SandovalCenters For Medicare Medicaid ServicesExchange Commission OnSera Prognostics IncClinical Laboratory Fee SchedulePregnancy CompanyEditorial PanelAmerican Medical AssociationLaboratory AnalysisMedicaid ServicesProprietary Laboratory AnalysisFinal Payment DeterminationsChief Executive OfficerSera PrognosticsDimes Report CardPrivate Securities Litigation Reform ActFinal ProspectusExchange CommissionQuarterly ReportsAnnual ReportsCurrent Reports
Investegate |Renalytix PLC Announcements | Renalytix PLC: Notice of Q1 FY22 Results - Vimarsana News

Investegate |Renalytix PLC Announcements | Renalytix PLC: Notice of Q1 FY22 Results

Published: December 2, 2021

Investegate announcements from Renalytix PLC, Notice of Q1 FY22 Results

Source: investegate.co.uk
Related Topics:
United KingdomCity OfNicholas MoorePaul Mcmanus Lianne CawthornePeter DenardoJames McculloughGary Clarence Daniel AdamsUs Canada Participant International DialDrug AdministrationInvestec BankUnited Kingdom International DialReport First Quarter Fiscal YearCall DetailsCanada Participant Toll Free Dial In NumberCanada Participant International Dial In NumberKingdom International Dial In NumberKingdom Local Dial In NumberNominated AdviserJoint BrokerBreakthrough DesignationInvestegate AnnouncementsInvestegate Company AnnouncementsRenalytix PlcEgulatory News ServiceEgulatory News Service And Regulatory
Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

Published: December 1, 2021

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldPeter DenardoErich SandovalExchange Commission OnSera Prognostics IncAlliance For MaternalPtb About Sera Prognostics IncMelinda Gates FoundationPrnewswire Sera Prognostics IncPregnancy CompanyNewborn Health ImprovementPrognostics IncSaharan AfricaProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth Risk PredictorNeonatal MedicineSouth AsianSaharan AfricanSera PrognosticsDimes Report CardPrivate Securities Litigation Reform Act
Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

Published: December 1, 2021

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldPeter DenardoErich SandovalExchange Commission OnSera Prognostics IncAlliance For MaternalPtb About Sera Prognostics IncMelinda Gates FoundationPrnewswire Sera Prognostics IncPregnancy CompanyNewborn Health ImprovementPrognostics IncSaharan AfricaProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth Risk PredictorNeonatal MedicineSouth AsianSaharan AfricanSera PrognosticsDimes Report CardPrivate Securities Litigation Reform Act
Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs - Vimarsana News

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs

Published: November 4, 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
Stanford UniversityUnited StatesSalt Lake CityGregoryc CritchfieldPeter DenardoWoodrow MyersErich SandovalExchange Commission OnSera Prognostics IncFreespira IncPrnewswire Sera Prognostics IncHealth IncBoard Of Trustees Stanford UniversityHealth EquityPersonalis IncGenomic HealthBoard Of Overseers Harvard UniversityHealth Services CorizonEquity AlliancePregnancy CompanyPublic Health Policy CommitteeNational Health Policy Advisor For The WellnessPrognostics IncSera PrognosticsNational Health Policy Advisor